Israel Roundup: Startups see 43 percent funding increase; AIDS drug royalty deal reached; Juniper expands R&D center; JVP exits Touch Clarity; startups complete rounds.
|
Memory chip maker expects challenging market for flash memory during first quarter.
|
Network equipment vendor admits CEO received two backdated stock option grants.
|
Former CEO, and VP of HR face expanded charges, as company pays $525,000 settlement.
|
Stock option problems will cause ‘significant changes’ to Mac maker’s quarterly results.
|
Former Brocade Communications officials become first executives charged in ongoing U.S. probe of backdated options.
|
The med-tech maker downplays concerns over options granted to three top execs.
|
Two top players join forces to protect Internet TV from viruses and other malware.
|
VC firm will invest $900 million in IT, life sciences, clean energy, pandemic preparedness, and bio defense.
|
Some 15 startups report funding Tuesday as venture capitalists disburse some of the money raised last year.
|
Security vendors combine to improve end-point security to mobile users.
|
Cisco may be old by Silicon Valley standards, but the networking giant is no worse for the wear.
|
Juniper Networks’ CTO indicates interest in entering switching.
|
CEO Scott Kriens says he has $1.5 billion to spend, and analysts and VCs offer some suggestions.
|
This year’s companies, guided by smart entrepreneurs, strong revenues, and impressive technological innovations, are ripe to transform the marketplace.
|